Table 3. Pharmacogenetic studies showing the effect of catechol-O-methyltransferase genotype polymorphism in neurological and psychiatric disorders.
COMT: catechol-O-methyltransferase; Met: Methionine; MTHFR: methylenetetrahydrofolate reductase; A allele: adenine allele; CA: cytosine-adenine; MLIC: motor levodopa-induced complications; PD: Parkinson's disease; AG: adenine-guanine; GG: guanine-guanine; AA: adenine-adenine; LID: levodopa-induced dyskinesia; BDNF: brain-derived neurotrophic factor; DAT: dopamine transporter; Val: Valine; ECT: electroconvulsive therapy; tDCS: transcranial direct current stimulation; MMT: methadone maintenance treatment; TC: thymine-cytosine; CC: cytosine-cytosine
Author | Year of publication | Type of study | No. of subjects | Purpose of study | Results /conclusion |
Peitl V et al. [31] | 2021 | Observational | 98 | To study how the long-acting aripiprazole influences cognitive functions in recent-onset schizophrenia. | COMT Met/Met genotype and COMT interaction with methylenetetrahydrofolate reductase (MTHFR) gene were found to have a positive association with attention and executive functioning. |
Nikolac Perkovic M et al. [32] | 2020 | Observational | 521 | To study the association between catechol-O-methyltransferase (COMT) rs4680 and rs4818 haplotype with treatment response to olanzapine in patients with schizophrenia. | A significant therapeutic response to olanzapine was found in schizophrenia patients with the COMT rs4680 A allele and rs4680-rs4818 C-A haplotype. |
Michałowska M et al. [33] | 2020 | Observational | 136 | To determine the association of gene polymorphisms with MLIC in Parkinson’s Disease (PD). | A positive association was found between a combination of AG BDNF, AG DAT, and GG COMT genotypes with MLIC. |
Dos Santos EUD et al. [34] | 2020 | Observational | 220 | To study the impact of variants in several genes on the development of levodopa-induced dyskinesia (LID) in patients with idiopathic PD. | COMT LL genotype was seen to increase the chances of developing LID. |
Zhao C et al. [35] | 2020 | Observational | 150 | To investigate the association of COMT genotype variants with variability in response to levodopa therapy in PD patients. | Single nucleotide polymorphisms other than rs4680 were found to have a possible association with variation in the daily dose of levodopa as well as susceptibility to the occurrence of dyskinesia after levodopa therapy. |
Tang Z et al. [36] | 2020 | Meta-analysis | 2845 | To study the association between COMT gene Val108/158Met and antidepressive treatment response. | COMT rs4680 variant was found to be significantly associated with antidepressive treatment. Patients with the GG or AG + GG variants responded better to ECT than patients with AA genotype. |
Brunoni AR et al. [37] | 2020 | Randomized control trial | 195 | To investigate whether neuroplasticity-associated SNPs like COMT gene and other gene variants affect the efficacy of tDCS or escitalopram therapy in major depression. | The results indicated non-significant dose-dependent effects of the Met allele and lower tDCS vs. placebo effects. |
McClintock SM et al. [38] | 2020 | Randomized control trial | 130 | To assess the neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression. | COMT and BDNF genotype polymorphisms were determined as potential moderators of neurocognitive effects. COMT rs4680 variant was found to affect verbal fluency outcomes. |
Duan L et al. [39] | 2020 | Observational | 820 | To study the association of COMT gene polymorphisms with response to MMT among opioid-dependent patients. | Patients with the TC or CC genotypes of the rs933271 variant had a higher chance of responding to MMT. |